A Renaissance for Old Drugs: Fosfomycin and Colistin
![](https://i0.wp.com/allphasepharma.com/dir/wp-content/uploads/2015/04/renaissance-drugs.jpg?resize=640%2C180&ssl=1)
Fosfomycin Who would have thought that a drug that has been around since 1969 [2] could become eligible for QIDP status in 2015? Well, Zavante Therapeutics recently garnered the coveted QIDP designation for fosfomycin IV. This formulation has been available Continue reading A Renaissance for Old Drugs: Fosfomycin and Colistin